Local News: Monroe, LA 

 | 

Sign Up

 | 

Sign In

Advertisment

Gilead Sciences News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Gilead Sciences News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Gilead Sciences News

News on Gilead Sciences continually updated from thousands of sources around the net.

18 hrs ago | Inside Bay Area

Foster City Planning Commission weighs Gilead expansion project

The Planning Commission will consider a proposed major expansion of Gilead Sciences' corporate campus at a meeting tonight and make a series of recommendations to the City Council.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Foster City, CA, Startups, Gilead Sciences

Wed Dec 02, 2009

Barron's

Gilead Shares Should Get Shot in Arm

Dow Jones Reprints: This copy is for your personal, non-commerical use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool on any article or visit www.djreprints.com PRACTICALLY IGNORED BY INVESTORS THIS YEAR, drug maker Gilead Sciences deserves more support for its leading ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, HIV/AIDS, Health

The Western Edition - Community Newsp...

Good medicine for a global community

Huge numbers of nonprofits exist that are devoted to caring, educating and treating patients diagnosed with HIV and other life threatening diseases.

Comment?

Related Topix: HIV/AIDS, Health, Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, Marketing

Mon Nov 30, 2009

Harlem World

Join Beyond the Diagnosis in Harlem

Gilead Sciences, Inc. cordially invites you to attend the Beyond the Diagnosis community based theater performance in Harlem, NY.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences

Sun Nov 29, 2009

Canada.com

China rolls out two HIV drugs to tackle resistance

China will provide two imported HIV drugs to patients who develop resistance to cheaper, domestic alternatives, state media said on Monday, going some way to meeting a key demand of AIDS treatment activists.

Comment?

Related Topix: HIV/AIDS, Health, Viread, Tenofovir (generic), Medicine, Medication, Biotech, Healthcare Industry

MELODIKA.net

Pearl Therapeutics Appoints Howie Rosen to Board of Directors

Pearl Therapeutics Inc., a biopharmaceutical company developing therapeutic products for the treatment of chronic respiratory diseases, today announced the appointment of Howie Rosen to the company's Board of Directors.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, Stanford University, Marketing

Fri Nov 27, 2009

Business Wire

Public relations, press release distribution, investor relations, SEC filing

MADISON, Wis.-- --BioSystem Development, LLC., a privately held life science analytics company, announces a recently completed investment round that raised just over 1.4 million dollars... LISLE, Illinois-- --SmartSignal Corporation ha annunciato oggi che Gas Natural ha selezionato il software SmartSignal EPI*Center per il monitoraggio di 22 ...

Comment?

Related Topix: Insurance, Rehabcare Group, GSI Commerce, Retail, Computers, Sporting Goods, Marketing, Carrollton, TX, Biotech, Medicine, Healthcare Industry

Wed Nov 25, 2009

The Big Sandy News

WHO probing drug resistant swine flu

Britain's Health Protection Agency said five cases have been confirmed in Wales of patients infected with H1N1 resistant to oseltamivir -- the generic name of Roche and Gilead Sciences Inc 's antiviral drug Tamiflu.

Comment?

Related Topix: Tamiflu, Oseltamivir (generic), Medicine, Medication, Biotech, Healthcare Industry, Centers for Disease Control and Prevention, Duke University, Epidemic, Natural Disasters

Tue Nov 24, 2009

PR-inside.com

Gilead and GlaxoSmithKline Announce Agreement to Commercialize...

Gilead Sciences, Inc. and GlaxoSmithKline today announced a licensing agreement to commercialize Viread for the treatment of chronic hepatitis B infection in adults in five countries in Asia.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Viread, Tenofovir (generic), Medication, GlaxoSmithKline, Startups, Gilead Sciences, Hepatitis

Sun Nov 22, 2009

Salem-News.com

A Few Things Parents Should Know About Tamiflu

The purpose of this article is to encourage the American people to read information on drugs they are being prescribed -- especially prescribed to their children -- and to read, read, read ingredients contained on labels -- especially what is being ingested by children.

Comment?

Related Topix: Tamiflu, Oseltamivir (generic), Medicine, Medication, Biotech, Healthcare Industry, Myrtle Beach, SC, Myrtle Beach Metro, H1N1 Influenza / Swine Flu, Health, Pediatrics

Thu Nov 19, 2009

Motley Fool

The Hottest Sector for 2010

While the market has staged a nice comeback since the spring and the economy seems to be slowly righting itself, things are still rough out there.

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Amgen, Healthcare Industry, Pfizer, Wellpoint Health Networks, Insurance

Tue Nov 17, 2009

The Motley Fool

A Big Upgrade for Sanofi-Aventis

Every day, the sun rises on Wall Street, and a plethora of professional analysts wake to issue new opinions on stocks.

Comment?

Related Topix: Biotech, SanofiSynthlabo, Construction, Berkshire Hathaway, Insurance, Investment Services, GlaxoSmithKline, Bristol Myers Squibb, Medicine, Healthcare Industry

Mon Nov 16, 2009

ETF Investor

H&Q Healthcare Investors Closed-End Fund Decently Valued

H&Q Healthcare Investors appears to a be a decent value now within the closed-end fund universe.

Comment?

Related Topix: HQ Healthcare Investors, Financial Services, Biotech, Medicine, Healthcare Industry, Celgene

Fri Nov 13, 2009

Tech Confidential Blog

Back channels

Over his 28 years, Burrill's clients have included Steve Jobs of Apple, Genentech, Amgen and Gilead Sciences.

Comment?

Related Topix: Investment Banking, Financial Services, Biotech, Medicine, Genentech, Amgen, Healthcare Industry, Computers, Steve Jobs, Apple Computer

Wed Nov 11, 2009

The Motley Fool

5-Star Stocks Poised to Pop: Gilead Sciences

Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS , the Fool's free investing community, biotech giant Gilead Sciences has earned a coveted five-star ranking .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, Financial Markets, H1N1 Influenza / Swine Flu, Health

Tue Nov 10, 2009

The Motley Fool

A Big Upgrade for Gilead Sciences

David Gardner called it. Hea TMs up 1,334%! See what Davida TMs recommending that you buy NEXT.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, Gilead Sciences, Financial Markets, Pfizer, Merck , SanofiSynthlabo

Mon Nov 09, 2009

Blogging Stocks

Cramer on BloggingStocks: Pelosi can't kill the health care sector

Filed under: Market matters , Abbott Laboratories , Aetna Inc , CIGNA Corp , Gilead Sciences , Stocks to Buy , Cramer on BloggingStocks TheStreet.com's Jim Cramer says the Senate is filled with more-savvy politicians, and the upside for beaten-down names is huge.

Comment?

Related Topix: Biotech, Abbott Laboratories, Aetna, Insurance, Cigna, Medicine, Healthcare Industry, Financial Markets

Earth Times

FreeBalance Shows Substantial Growth in Latest Internal Audit

FreeBalance , a leading global provider of software solutions for public financial management, is pleased to announce the results of its most recent internal audit which show a dramatic increase in the size and scope of FreeBalance Government Resource Planning software implementations worldwide since 2006.

Comment?

Related Topix: Accounting, Software, Europe, Kosovo, Marketing, Biotech, Medicine, Healthcare Industry, Johnson City Metro

Sat Nov 07, 2009

M2.com

Graceway Pharmaceuticals acquires rights to Gilead's investigational molecule GS 9191

GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Services, Investment Services

Fri Nov 06, 2009

American Chronicle

News and FDA Updates for Genta

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/04/09, Genta Incorporated announced the Company will release its third quarter 2009 financial results on Monday, November 16, 2009.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech, Medicine, Genta, Healthcare Industry, SurModics, Medical Equipment, Chemicals, Opinion

Monroe Jobs

Also on Topix